Ken Macnamara is the founder of Trogenix. Trogenix has raised $111M in total funding. Latest round: Series A. Based in Edinburgh, United Kingdom.
Ken Macnamara is the Chief Executive Officer of Trogenix, a clinical-stage biotech company focused on developing precision genetic medicine for solid tumors. Trogenix recently announced a $95 million Series A financing round to accelerate its clinical trials and advance its Odysseus platform.
Full founder directory · Investor directory · Company funding database · Fundraising library